![](https://cdn.physiciansweekly.com/wp-content/uploads/2024/05/people-with-HIV.png)
DTG/3TC and B/F/TAF Effects on HIV-1 Reservoir
The following is a summary of “In-depth Analysis of the HIV Reservoir Confirms Effectiveness and Safety of Dolutegravir/Lamivudine in a Phase 4 Randomized Controlled Switch Trial (RUMBA)”, published in the September 2024 issue of Infectious Diseases by …